Change of direction
First off lets state that the Tandem earnings we’re great any way you look at them. Strong US sales, improving international sales and of course raising guidance. None of this should surprise anyone as for months we’ve been stating that when it comes to conventional pumps the Control-IQ is beating any Medtronic system like a drum. However as we have also been saying while Tandem is kicking Medtronic’s butt they are becoming concerned about Insulet – who reports later today – and has the OmniPod 5 coming soon.
Take a look at these comments made by John Sheridan . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.